Viatris Inc (VTRS)
10.98
-0.04
(-0.36%)
USD |
NASDAQ |
May 17, 16:00
10.97
-0.01
(-0.09%)
After-Hours: 20:00
Viatris Price to Book Value: 0.6532 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.6532 |
| May 16, 2024 | 0.6556 |
| May 15, 2024 | 0.6586 |
| May 14, 2024 | 0.6627 |
| May 13, 2024 | 0.6758 |
| May 10, 2024 | 0.6639 |
| May 09, 2024 | 0.6675 |
| May 08, 2024 | 0.7026 |
| May 07, 2024 | 0.6972 |
| May 06, 2024 | 0.7032 |
| May 03, 2024 | 0.7008 |
| May 02, 2024 | 0.6901 |
| May 01, 2024 | 0.6919 |
| April 30, 2024 | 0.6883 |
| April 29, 2024 | 0.7008 |
| April 26, 2024 | 0.6883 |
| April 25, 2024 | 0.6824 |
| April 24, 2024 | 0.6871 |
| April 23, 2024 | 0.6757 |
| April 22, 2024 | 0.6691 |
| April 19, 2024 | 0.6691 |
| April 18, 2024 | 0.6614 |
| April 17, 2024 | 0.6602 |
| April 16, 2024 | 0.6614 |
| April 15, 2024 | 0.6733 |
| Date | Value |
|---|---|
| April 12, 2024 | 0.6739 |
| April 11, 2024 | 0.6882 |
| April 10, 2024 | 0.6965 |
| April 09, 2024 | 0.703 |
| April 08, 2024 | 0.6989 |
| April 05, 2024 | 0.7018 |
| April 04, 2024 | 0.6995 |
| April 03, 2024 | 0.7149 |
| April 02, 2024 | 0.7102 |
| April 01, 2024 | 0.7102 |
| March 31, 2024 | |
| March 28, 2024 | 0.6928 |
| March 27, 2024 | 0.6864 |
| March 26, 2024 | 0.6731 |
| March 25, 2024 | 0.6864 |
| March 22, 2024 | 0.687 |
| March 21, 2024 | 0.6969 |
| March 20, 2024 | 0.6893 |
| March 19, 2024 | 0.6887 |
| March 18, 2024 | 0.6823 |
| March 15, 2024 | 0.6928 |
| March 14, 2024 | 0.6858 |
| March 13, 2024 | 0.6992 |
| March 12, 2024 | 0.6998 |
| March 11, 2024 | 0.6945 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5042
Minimum
Oct 27 2023
1.744
Maximum
Dec 30 2020
0.7405
Average
0.7099
Median
Jul 13 2020
Price to Book Value Benchmarks
| Pfizer Inc | 1.759 |
| Johnson & Johnson | 5.315 |
| Masimo Corp | 4.826 |
| Iovance Biotherapeutics Inc | 4.214 |
| Evolus Inc | 46.14 |
Price to Book Value Related Metrics
| PS Ratio | 0.8634 |
| Price to Free Cash Flow | 6.630 |
| Price | 10.98 |
| Earnings Yield | -0.55% |
| Market Cap | 13.07B |
| Operating PE Ratio | 15.25 |
| Normalized PE Ratio | 76.93 |